- Name: GENOMEUP SRL
- Website: omzey.com
- Market: Private Markets
- Main Currency: -
- Share Price: -
- Market Cap: -
- Location: Roma, Italy
Data processing, hosting and related activities
Income Statement
A.
TOTAL PRODUCTION VALUE 1,486,462€
A.1.
Revenues from sales and services 1,269,584€
A.5.
Total other revenues 216,878€
-- > other revenues of which contributions for operating expenses 111,700€
Other revenues 105,178€
B.
PRODUCTION COSTS 3,604,448€
B.6.
Purchase of materials 74,089€
B.7.
Services 1,955,387€
B.8.
Leased assets 126,638€
B.9.a.
wages/salaries 885,282€
B.9.b.
Social security costs 252,454€
B.9.c.
Severance payments 58,370€
B.9.e.
Other costs 30,432€
B.9.
c+d+e severance payments + pensions + other costs 88,802€
B.9.
TOT staff costs 1,226,538€
B.10.a.
Depreciation of intangibles 98,761€
B.10.b.
Depreciation of tangibles 1,796€
B.10.a.+b.+c.
Depreciation and impairment of fixed assets 100,557€
B.10.
TOT depreciation and impairment 100,557€
B.14.
Other operating charges 121,239€
*
Difference between value and cost of production (a - b) -2,117,986€
C.
TOTAL REVENUES AND FINANCIAL CHARGES -15,072€
C.17.
To other 15,072€
C.17.
Total financial charges 15,072€
*
Result before taxes -2,133,058€
21.
PROFIT/LOSS FOR THE YEAR -2,133,058€
Balance Sheet
B.
TOTAL FIXED ASSETS 292,871€
B.I.
TOTAL INTANGIBLE FIXED ASSETS 283,728€
B.II.
TOTAL TANGIBLE FIXED ASSETS 7,853€
B.III.
TOTAL FINANCIAL FIXED ASSETS 1,290€
C.
CURRENT ASSETS 3,391,852€
C.II.
TOTAL CREDITS 1,399,346€
C.II.>>
SHORT TERM CREDITS 1,399,346€
C.IV.
Cash equivalents 1,992,506€
D.
Accruals and deferrals 10,192€
Total assets 3,694,915€
A.
TOTAL NET WORTH 2,037,874€
A.I.
Share capital 99,028€
A.II.
Share premium reserve 5,608,020€
A.IV.
Legal reserve 181€
A.V.
Statutory reserve 10,273€
A.VIII.
Profit/Loss carried forward -1,546,570€
A.IX.
Profit/Loss for the year -2,133,058€
C.
Severance payments 114,175€
D.
TOTAL DEBTS 1,496,240€
D.>>
SHORT TERMS DEBTS 1,496,240€
E.
ACCRUALS AND DEFERRALS 46,626€
TOTAL LIABILITIES 3,694,915€
Balance Sheet History
Income Statement
A.
TOTAL PRODUCTION VALUE 896,879€
A.1.
Revenues from sales and services 716,231€
A.5.
Total other revenues 180,648€
-- > other revenues of which contributions for operating expenses 135,612€
B.
PRODUCTION COSTS 2,442,380€
B.6.
Purchase of materials 16,423€
B.7.
Services 1,262,767€
B.8.
Leased assets 119,036€
B.9.a.
wages/salaries 673,022€
B.9.b.
Social security costs 216,403€
B.9.c.
Severance payments 49,794€
B.9.
c+d+e severance payments + pensions + other costs 49,794€
B.9.
TOT staff costs 939,219€
B.10.a.
Depreciation of intangibles 81,151€
B.10.b.
Depreciation of tangibles 1,092€
B.10.a.+b.+c.
Depreciation and impairment of fixed assets 82,243€
B.10.
TOT depreciation and impairment 82,243€
B.14.
Other operating charges 22,692€
C.
TOTAL REVENUES AND FINANCIAL CHARGES -1,069€
C.17.
Total financial charges 1,069€
*
Result before taxes -1,546,570€
21.
PROFIT/LOSS FOR THE YEAR -1,546,570€
Balance Sheet
B.
TOTAL FIXED ASSETS 305,764€
B.I.
TOTAL INTANGIBLE FIXED ASSETS 299,823€
B.II.
TOTAL TANGIBLE FIXED ASSETS 5,941€
C.
CURRENT ASSETS 1,097,974€
C.II.
TOTAL CREDITS 1,015,288€
C.II.>>
SHORT TERM CREDITS 1,015,288€
C.IV.
Cash equivalents 82,686€
D.
Accruals and deferrals 41,412€
Total assets 1,445,150€
A.
TOTAL NET WORTH 470,933€
A.I.
Share capital 50,000€
A.II.
Share premium reserve 169,547€
A.IV.
Legal reserve 181€
A.V.
Statutory reserve 10,273€
A.VI.
Other reserves 1,787,502€
A.IX.
Profit/Loss for the year -1,546,570€
D.
TOTAL DEBTS 843,599€
D.>>
SHORT TERMS DEBTS 843,599€
E.
ACCRUALS AND DEFERRALS 51,524€
TOTAL LIABILITIES 1,445,150€
⚠️ Data Normalization Applied ⚠️
Some values in this chart have been scaled down to improve readability when datasets have significantly different scales. Normalized data is indicated by dashed lines and diagonal striped bars.
Some values in this chart have been scaled down to improve readability when datasets have significantly different scales. Normalized data is indicated by dashed lines and diagonal striped bars.
*Data displayed on this chart is taken from the company's balance sheets and is as accurate as it can get. Balance sheets are normally filed once per year, so this Chart can take some time to get up to date.
Genomeup Srl - Ownership & Management
Main shareholders displayed on a pie chart.
Last updated: October 23, 2025
Main Shareholders
Managers
- Bruno Dallapiccola - Chairman of board of directors
- Simone Gardini - Managing director
- Aurelio Mezzotero - Director
- Francesco Tordelli - Director
- Patrick Herve Landi - Director
- Carlo Geronimo Cardia - Single auditor